Return to homepagePandemic Pact

Melatonin and melatoninergic drugs for the prevention and treatment of COVID-19

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    ANR

  • Principal Investigator

    Ralf JOCKERS

  • Research Location

    France

  • Lead Research Institution

    Institut Cochin ? Inserm

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The MELATOVID project coordinated by Ralf Jockers (U1016 - Institut Cochin - Inserm) aims to assess the potential of melatonin and its derivatives in order to provide a rapid, preventive or therapeutic solution against Covid-19 infection. He will evaluate the effect of melatoninergic drugs and their associated mechanisms of action on cell models infected with the SARS-CoV-2 virus, and in vivo.